Venture-Med Angel Investment Group is a membership organization of accredited investors dedicated to funding and mentoring new healthcare start ups. We focus on medical devices, healthcare IT, and mobile health platforms that will enhance patient safety and outcomes. Apply for Membership.
We provide unparalleled access, mentorship and support to early-stage companies that have IP, a strong team, domain expertise and vision. Learn more about our Screening and Evaluation Process.
We are excited to bring you the best experience in previewing innovation in healthcare. Each company is screened for maturity and valued on a 20 point multi-factor scale. Please register to join us as a guest at our next event.
View Upcoming Events.
We are pleased to announce our new funding platform, MedXForward. Read more.
FREETOWN (Reuters) - The worst ever Ebola outbreak is causing enormous damage to West African economies as foreign businessmen quit the region, the African Development Bank said, while a leading medical charity branded the international response "entirely inadequate." […]
NEW YORK (Reuters Health) – That Chilean sea bass from the local grocery store could have twice the methylmercury that’s expected – if it comes from a region other than indicated on the label, a new study says. […]
NEW YORK (Reuters Health) – Even people at significant risk for heart attacks and strokes can take an active role in reducing their own high blood pressure, by measuring it themselves and adjusting their medications, according to a new study from the UK. […]
CHICAGO (Reuters) - Fewer than half of Saudi Arabian patients in a study passed the Middle East Respiratory Syndrome virus to household members, and many of those who developed secondary infections contracted mild cases of MERS, global researchers reported on Wednesday. […]
ORLANDO Fla. (Reuters) - A Florida company plans to build what it believes will be the biggest medical marijuana factory in the country, hoping the economy of scale will lower the cost of the drug which is not covered by insurance. […]
CHICAGO (Reuters) - The U.S. Centers for Disease Control and Prevention said on Wednesday it flew an employee back to the United States from West Africa by chartered plane after the staff member came in contact with an international healthcare worker who later tested positive for Ebola. […]
Westby G. Fisher, MD, FACC is a board certified internist, cardiologist, and cardiac electrophysiologist practicing at NorthShore University HealthSystem in Evanston, IL, USA and is a Clinical Associate Professor of Medicine at University of Chicago's Pritzker School of Medicine. By Westby G. Fisher, MD, FACC As I begin another year teaching EKG's […]
Botox-maker Allergan acquiesces to Valeant Pharmaceuticals' demands for a special shareholder meeting, but takes to court to prevent Valeant and its compatriots from voting their shares. Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.Legal News, News Well, Cosmetic/Aesthetic, Mergers & Acquisitionsread more […]
Medtech titan Medtronic enrolls the 1st patients in the AdaptResponse clinical trial to evaluate its adaptive cardiac rhythm management technology. Medtronic (NYSE:MDT) touted the launch of its AdaptResponse trial, the largest study of its kind evaluating the company's AdaptivCRT algorithm for personalizing cardiac resynchronization therapy in treatment […]
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry. MassDevice.comNews Well, Plus 3read […]
The FDA puts its highest-risk Class I label on the recall of DePuy Synthes' jaw stabilizing system over a defect that may result in injury or death in infants. FDA regulators put their highest-risk Class I label on the recall of DePuy Synthes' Craniomaxillofacial Distraction System after the company reported 15 injuries associated with the jaw impl […]
Yet another shareholder sues Covidien and its leaders, accusing them of short-changing investors in the $43 billion acquisition by Medtronic. Covidien, MedtronicLegal News, News Well, Medtronic buys Covidien, Mergers & Acquisitions, Minnesotaread more […]